Expression of serum miR ‐ 135a in patients with allergic rhinitis and its relationship with Treg/Th17 balance
The Kaohsiung Journal of Medical Sciences · 2025-01 · 41 (1)
DOI: 10.1002/kjm2.12918 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, online erschienen am 11.12.2024. Verfasst von Jing Cai und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Octolaryngology, First Affiliated Hospital of Kunming Medical University, Kunming, People's Republic of China. Hauptthemen laut MEDLINE: MicroRNAs, T-Lymphocytes, Regulatory, Rhinitis, Allergic, Th17 Cells. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The dysregulation of microRNA (miRNA) expression contributes to the development of allergic rhinitis (AR). This study investigates serum miR‐135a levels and their association with regulatory T cell (Treg) and T helper cell 17 (Th17) balance in AR patients. A total of 93 AR patients and 76 healthy controls were retrospectively recruited. Levels of serum miR‐135a , peripheral blood Th17 and Treg cells, and Treg/Th17‐related cytokines were measured. We assessed the diagnostic value of serum miR‐135a for AR and its relationship with Treg/Th17 balance. AR patients showed significantly elevated immunoglobulin E (IgE), peripheral blood Th17 cells, and IL‐17 and IL‐6 levels, alongside reduced serum miR‐135a , Treg cells, IL‐10, TGF‐β1, and Treg/Th17 ratios. A serum miR‐135a of ≤0.536 demonstrated diagnostic potential for AR. Patients with higher serum miR‐135a levels displayed increased Treg cell level and Treg/Th17 ratios, reduced Th17 cell, and lower total nasal symptom score (TNSS). Serum miR‐135a levels in AR patients negatively correlated with TNSS, IL‐17, IL‐6, and Th17 cell percentages, and positively correlated with IL‐10, TGF‐β1, Treg cell percentages, and Treg/Th17 ratios. Collectively, decreased serum miR‐135a levels in AR patients are associated with Treg/Th17 balance, supporting miR‐135a as a potential biomarker for AR diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Octolaryngology, First Affiliated Hospital of Kunming Medical University, Kunming, People's Republic of China.
- Department of Rehabilitation Medicine, First Affiliated Hospital of Kunming Medical University, Kunming, People's Republic of China.
ORCID-Profile: Sheng-Liu Shi
Zitieren
APA
Cai, J., Wang, F., & Shi, S. L. (2025). Expression of serum miR ‐ 135a in patients with allergic rhinitis and its relationship with Treg/Th17 balance. The Kaohsiung Journal of Medical Sciences, 41(1). https://doi.org/10.1002/kjm2.12918
Vancouver
Cai J, Wang F, Shi SL. Expression of serum miR ‐ 135a in patients with allergic rhinitis and its relationship with Treg/Th17 balance. The Kaohsiung Journal of Medical Sciences. 2025;41(1). doi:10.1002/kjm2.12918
BibTeX
@article{Cai2025,
author = {Cai, Jing and Wang, Fang and Shi, Sheng-Liu},
title = {Expression of serum miR ‐ 135a in patients with allergic rhinitis and its relationship with Treg/Th17 balance},
journal = {The Kaohsiung Journal of Medical Sciences},
year = {2025},
volume = {41},
number = {1},
doi = {10.1002/kjm2.12918}
}
EUVIMED